• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高度特异性膦三肽对映异构体与血管紧张素转化酶复合物的晶体结构。

Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme.

机构信息

Department of Biology and Biochemistry, University of Bath, UK.

出版信息

FEBS J. 2014 Feb;281(3):943-56. doi: 10.1111/febs.12660. Epub 2013 Dec 24.

DOI:10.1111/febs.12660
PMID:24289879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4154125/
Abstract

Human somatic angiotensin-I converting enzyme (ACE) is a zinc-dependent dipeptidyl carboxypeptidase and a central component of the renin angiotensin aldosterone system (RAAS). Its involvement in the modulation of physiological actions of peptide hormones has positioned ACE as an important therapeutic target for the treatment of hypertension and cardiovascular disorders. Here, we report the crystal structures of the two catalytic domains of human ACE (N- and C-) in complex with FI, the S enantiomer of the phosphinic ACE/ECE-1 (endothelin converting enzyme) dual inhibitor FII, to a resolution of 1.91 and 1.85 Å, respectively. In addition, we have determined the structure of AnCE (an ACE homologue from Drosophila melanogaster) in complex with both isomers. The inhibitor FI (S configuration) can adapt to the active site of ACE catalytic domains and shows key differences in its binding mechanism mostly through the reorientation of the isoxazole phenyl side group at the P₁' position compared with FII (R configuration). Differences in binding are also observed between FI and FII in complex with AnCE. Thus, the new structures of the ACE-inhibitor complexes presented here provide useful information for further exploration of ACE inhibitor pharmacophores involving phosphinic peptides and illustrate the role of chirality in enhancing drug specificity.

摘要

人源体血管紧张素转化酶(ACE)是一种锌依赖性二肽羧基肽酶,也是肾素-血管紧张素-醛固酮系统(RAAS)的核心组成部分。它在调节肽类激素的生理作用方面的作用,使 ACE 成为治疗高血压和心血管疾病的重要治疗靶点。在这里,我们报告了人源 ACE(N-和 C-)两个催化结构域与 FI(ACE/ECE-1(内皮素转化酶)双抑制剂 FII 的 S 对映异构体)复合物的晶体结构,分辨率分别为 1.91 和 1.85 Å。此外,我们还确定了来自黑腹果蝇的 ACE 同源物 AnCE 与两种异构体复合物的结构。抑制剂 FI(S 构型)可以适应 ACE 催化结构域的活性部位,与 FII(R 构型)相比,其结合机制主要通过 P₁'位置的异噁唑苯侧基的重定向表现出关键差异。FI 与 FII 分别与 AnCE 形成复合物时,结合也存在差异。因此,这里呈现的 ACE-抑制剂复合物的新结构为进一步探索涉及膦酸肽的 ACE 抑制剂药效团提供了有用信息,并说明了手性在增强药物特异性方面的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/73508e149572/febs-281-943-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/8091587d1360/febs-281-943-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/d2671d34eb24/febs-281-943-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/2e177b75fcc8/febs-281-943-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/31affbaee513/febs-281-943-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/73508e149572/febs-281-943-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/8091587d1360/febs-281-943-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/d2671d34eb24/febs-281-943-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/2e177b75fcc8/febs-281-943-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/31affbaee513/febs-281-943-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/4154125/73508e149572/febs-281-943-g5.jpg

相似文献

1
Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme.高度特异性膦三肽对映异构体与血管紧张素转化酶复合物的晶体结构。
FEBS J. 2014 Feb;281(3):943-56. doi: 10.1111/febs.12660. Epub 2013 Dec 24.
2
Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide.新型高度特异的膦酰三肽抑制人血管紧张素转化酶(ACE)的机制。
Biochem J. 2011 May 15;436(1):53-9. doi: 10.1042/BJ20102123.
3
Crystal structure of a phosphonotripeptide K-26 in complex with angiotensin converting enzyme homologue (AnCE) from Drosophila melanogaster.与果蝇同源的血管紧张素转换酶(AnCE)复合物中磷酸三肽 K-26 的晶体结构。
Biochem Biophys Res Commun. 2010 Jul 30;398(3):532-6. doi: 10.1016/j.bbrc.2010.06.113. Epub 2010 Jul 1.
4
The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380.与C结构域特异性抑制剂RXPA380结合的睾丸血管紧张素转换酶的结构
Biochemistry. 2007 May 8;46(18):5473-8. doi: 10.1021/bi700275e. Epub 2007 Apr 18.
5
Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.RXPA380的结构决定因素,一种有效的且高度选择性的血管紧张素转换酶C结构域抑制剂。
Biochemistry. 2004 Jun 29;43(25):8048-54. doi: 10.1021/bi049504q.
6
Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril.血管紧张素转化酶与卡托普利硒类似物复合物的结构特征。
FEBS J. 2011 Oct;278(19):3644-50. doi: 10.1111/j.1742-4658.2011.08276.x. Epub 2011 Sep 8.
7
The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition.血管紧张素转换酶突变对N结构域选择性抑制的动力学和动态学的影响。
FEBS J. 2016 Nov;283(21):3941-3961. doi: 10.1111/febs.13900. Epub 2016 Oct 5.
8
The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407.人血管紧张素转换酶 N 端结构域:N-糖基化的作用及与 N 端结构域特异性膦酸抑制剂 RXP407 复合物的晶体结构。
J Biol Chem. 2010 Nov 12;285(46):35685-93. doi: 10.1074/jbc.M110.167866. Epub 2010 Sep 8.
9
Functional conservation of the active sites of human and Drosophila angiotensin I-converting enzyme.人类和果蝇血管紧张素I转换酶活性位点的功能保守性。
Biochemistry. 2000 Aug 1;39(30):8963-9. doi: 10.1021/bi000593q.
10
Drosophila melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of the mammalian homologue and does not require glycosylation for secretion and enzymic activity.在毕赤酵母中表达的果蝇血管紧张素I转换酶类似于哺乳动物同源物的C结构域,分泌和酶活性不需要糖基化。
Biochem J. 1996 Aug 15;318 ( Pt 1)(Pt 1):125-31. doi: 10.1042/bj3180125.

引用本文的文献

1
Metabolites Isolated from Sch. Bip and Their Synthesized Oximes Inhibit Angiotensin I-Converting Enzyme Activity in Vascular Smooth Muscle.从Sch. Bip中分离出的代谢产物及其合成的肟类化合物可抑制血管平滑肌中血管紧张素I转换酶的活性。
Int J Mol Sci. 2025 Apr 17;26(8):3786. doi: 10.3390/ijms26083786.
2
Molecular Basis of Dipeptide Recognition in Angiotensin I-Converting Enzyme Homologue, AnCE.血管紧张素I转换酶同源物AnCE中识别二肽的分子基础
Biomolecules. 2025 Apr 16;15(4):591. doi: 10.3390/biom15040591.
3
Phosphinic Peptides as Tool Compounds for the Study of Pharmacologically Relevant Zn-Metalloproteases.

本文引用的文献

1
The predicated demise of racemic new molecular entities is an exaggeration.外消旋新分子实体注定会消亡的说法有些夸张。
Nat Rev Drug Discov. 2012 Dec;11(12):972-3. doi: 10.1038/nrd3657-c1.
2
Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides.天然抑制肽对人血管紧张素转化酶(ACE)活性的分子识别与调控。
Sci Rep. 2012;2:717. doi: 10.1038/srep00717. Epub 2012 Oct 9.
3
Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide.
次膦酸肽作为研究药理学相关锌金属蛋白酶的工具化合物。
ACS Pharmacol Transl Sci. 2022 Nov 28;5(12):1228-1253. doi: 10.1021/acsptsci.2c00183. eCollection 2022 Dec 9.
4
Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective.小分子血管紧张素转换酶抑制剂:药物化学视角
Front Pharmacol. 2022 Nov 1;13:968104. doi: 10.3389/fphar.2022.968104. eCollection 2022.
5
The Drosophila melanogaster ACE2 ortholog genes are differently expressed in obesity/diabetes and aging models: Implications for COVID-19 pathology.果蝇 ACE2 直系同源基因在肥胖/糖尿病和衰老模型中表达不同:对 COVID-19 病理的影响。
Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166551. doi: 10.1016/j.bbadis.2022.166551. Epub 2022 Sep 15.
6
Cryo-EM reveals mechanisms of angiotensin I-converting enzyme allostery and dimerization.低温电镜揭示血管紧张素转化酶变构和二聚化的机制。
EMBO J. 2022 Aug 16;41(16):e110550. doi: 10.15252/embj.2021110550. Epub 2022 Jul 12.
7
Conformational Variation in Enzyme Catalysis: A Structural Study on Catalytic Residues.酶催化中的构象变化:催化残基的结构研究。
J Mol Biol. 2022 Apr 15;434(7):167517. doi: 10.1016/j.jmb.2022.167517. Epub 2022 Feb 28.
8
ACE and ACE2: insights from and implications for COVID-19.血管紧张素转换酶与血管紧张素转换酶2:关于2019冠状病毒病的见解与启示
Heliyon. 2021 Dec;7(12):e08555. doi: 10.1016/j.heliyon.2021.e08555. Epub 2021 Dec 7.
9
Structure of procarboxypeptidase B1 and its binding with Dengue virus for controlling infection.脯羧肽酶 B1 的结构及其与登革病毒的结合用于控制感染。
Life Sci Alliance. 2021 Nov 8;5(1). doi: 10.26508/lsa.202101211. Print 2022 Jan.
10
Structure of Aedes aegypti carboxypeptidase B1-inhibitor complex uncover the disparity between mosquito and non-mosquito insect carboxypeptidase inhibition mechanism.埃及伊蚊羧肽酶 B1 抑制剂复合物的结构揭示了蚊子和非蚊子昆虫羧肽酶抑制机制的差异。
Protein Sci. 2021 Dec;30(12):2445-2456. doi: 10.1002/pro.4212. Epub 2021 Nov 5.
新型高度特异的膦酰三肽抑制人血管紧张素转化酶(ACE)的机制。
Biochem J. 2011 May 15;436(1):53-9. doi: 10.1042/BJ20102123.
4
The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407.人血管紧张素转换酶 N 端结构域:N-糖基化的作用及与 N 端结构域特异性膦酸抑制剂 RXP407 复合物的晶体结构。
J Biol Chem. 2010 Nov 12;285(46):35685-93. doi: 10.1074/jbc.M110.167866. Epub 2010 Sep 8.
5
High-resolution crystal structures of Drosophila melanogaster angiotensin-converting enzyme in complex with novel inhibitors and antihypertensive drugs.果蝇黑腹果蝇血管紧张素转换酶与新型抑制剂和抗高血压药物复合物的高分辨率晶体结构。
J Mol Biol. 2010 Jul 16;400(3):502-17. doi: 10.1016/j.jmb.2010.05.024. Epub 2010 May 19.
6
Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril.用赖诺普利的一种新型衍生物对血管紧张素转化酶的域选择性抑制剂结合进行表征。
Biochem J. 2010 Apr 28;428(1):67-74. doi: 10.1042/BJ20100056.
7
XDS.XDS.(这个词如果没有更多背景信息,很难准确翻译出更有意义的内容,直接保留原文是一种处理方式,或者音译为“克斯达斯”之类,但感觉都不太符合常规翻译场景,你可以补充更多关于这个词的信息以便我更准确翻译 )
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32. doi: 10.1107/S0907444909047337. Epub 2010 Jan 22.
8
MolProbity: all-atom structure validation for macromolecular crystallography.MolProbity:用于大分子晶体学的全原子结构验证
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21. doi: 10.1107/S0907444909042073. Epub 2009 Dec 21.
9
Inhibition of zinc metallopeptidases in cardiovascular disease--from unity to trinity, or duality?抑制心血管疾病中的锌金属肽酶——从统一到三位一体,还是二元论?
Curr Pharm Des. 2009;15(31):3606-21. doi: 10.2174/138161209789271889.
10
Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.膦三肽作为双重血管紧张素转换酶 C 域和内皮素转换酶 1 抑制剂。
J Med Chem. 2010 Jan 14;53(1):208-20. doi: 10.1021/jm9010803.